{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:37:03Z","timestamp":1790800623096,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016286","name":"Urmia University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cca.2026.120829","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:09:37Z","timestamp":1767888577000},"page":"120829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["C-peptide in polycystic ovary syndrome"],"prefix":"10.1016","volume":"582","author":[{"given":"Faezeh","family":"Mahd Gharebagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asra","family":"Zeinalpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozhina Sadat","family":"Pirouzmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojat","family":"Ghasemnejad-Berenji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortaza","family":"Taheri-Anganeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.cca.2026.120829_bb0005","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.3390\/ijms25169037","article-title":"The pathophysiological mechanism and clinical treatment of polycystic ovary syndrome: A molecular and cellular review of the literature","volume":"25","author":"Chang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.120829_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2021.100085","article-title":"A review: Brief insight into polycystic ovarian syndrome","volume":"3","author":"Bulsara","year":"2021","journal-title":"Endocr. metab. Sci."},{"issue":"4","key":"10.1016\/j.cca.2026.120829_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.mefs.2017.05.007","article-title":"An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population","volume":"22","author":"Bharathi","year":"2017","journal-title":"Middle East Fertil. Soc. J."},{"key":"10.1016\/j.cca.2026.120829_bb0020","series-title":"Seminars in Reproductive Medicine","article-title":"A summary on polycystic ovary syndrome: Diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines","author":"Neven","year":"2018"},{"issue":"2","key":"10.1016\/j.cca.2026.120829_bb0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/clinem\/dgab613","article-title":"Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences","volume":"107","author":"Riestenberg","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cca.2026.120829_bb0030","first-page":"43","volume":"28","author":"Powers","year":"2015","journal-title":"Trends in standard workup performed by pediatric subspecialists for the diagnosis of adolescent polycystic ovary syndrome."},{"issue":"2","key":"10.1016\/j.cca.2026.120829_bb0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpag.2014.05.006","article-title":"Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence","volume":"28","author":"S\u0131klar","year":"2015","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"issue":"6","key":"10.1016\/j.cca.2026.120829_bb0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000479371","article-title":"An international consortium update: Pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Horm. Res. Paediatr."},{"issue":"5","key":"10.1016\/j.cca.2026.120829_bb0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.cca.2026.120829_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mcna.2022.10.004","article-title":"Polycystic ovarian syndrome","volume":"107","author":"Shrivastava","year":"2023","journal-title":"Med. Clin. North Am."},{"issue":"1","key":"10.1016\/j.cca.2026.120829_bb0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.17826\/cumj.782931","article-title":"Polikistik over sendromu bulunan kad\u0131nlarda glikoz potasyum oran\u0131n\u0131n tan\u0131sal de\u011ferinin ins\u00fclin ile kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131","volume":"46","author":"G\u00fcrb\u00fcz","year":"2021","journal-title":"Cukurova Med. J."},{"issue":"1","key":"10.1016\/j.cca.2026.120829_bb0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/15438600490424479","article-title":"Molecular and cellular effects of C-peptide\u2014new perspectives on an old peptide","volume":"5","author":"Wahren","year":"2004","journal-title":"J. Diabetes Res."},{"issue":"6","key":"10.1016\/j.cca.2026.120829_bb0065","first-page":"165","article-title":"C-peptide and its association with anti-m\u00fcllerian hormone in women with polycystic ovary syndrome","volume":"58","author":"Hmood","year":"2022","journal-title":"Appl. Biochem. Microbiol."},{"issue":"3","key":"10.1016\/j.cca.2026.120829_bb0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","article-title":"A practical review of C-peptide testing in diabetes","volume":"8","author":"Leighton","year":"2017","journal-title":"Diabetes Therapy"},{"issue":"01","key":"10.1016\/j.cca.2026.120829_bb0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.9790\/0853-1601012023","article-title":"To study the status of LH: FSH ratio in obese and non-obese patients of polycystic ovarian syndrome","volume":"16","author":"Lal","year":"2017","journal-title":"IOSR J. Dent. Med. Sci."},{"issue":"5","key":"10.1016\/j.cca.2026.120829_bb0080","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1210\/jc.2017-00131","article-title":"Functional hypothalamic amenorrhea: An endocrine society clinical practice guideline","volume":"102","author":"Gordon","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cca.2026.120829_bb0085","doi-asserted-by":"crossref","first-page":"260","DOI":"10.14740\/jocmr3325w","article-title":"The role of C-peptide as marker of cardiometabolic risk in women with polycystic ovary syndrome: A controlled study","volume":"10","author":"de Medeiros","year":"2018","journal-title":"J. Clin. Med. Res."},{"issue":"5","key":"10.1016\/j.cca.2026.120829_bb0090","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3390\/ijms17050744","article-title":"Postprandial C-peptide to glucose ratio as a marker of \u03b2 cell function: Implication for the management of type 2 diabetes","volume":"17","author":"Saisho","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.cca.2026.120829_bb0095","doi-asserted-by":"crossref","first-page":"E955","DOI":"10.1152\/ajpendo.00130.2014","article-title":"Physiological effects and therapeutic potential of proinsulin C-peptide","volume":"307","author":"Yosten","year":"2014","journal-title":"Am. J. Phys.-Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.cca.2026.120829_bb0100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00018-007-6467-6","article-title":"Cellular internalization of proinsulin C-peptide","volume":"64","author":"Lindahl","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.cca.2026.120829_bb0105","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1074\/jbc.M109.053587","article-title":"Proinsulin C-peptide regulates ribosomal RNA expression","volume":"285","author":"Lindahl","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.cca.2026.120829_bb0110","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1007\/s00125-009-1476-7","article-title":"C-peptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes","volume":"52","author":"Luppi","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.120829_bb0115","doi-asserted-by":"crossref","first-page":"1256093","DOI":"10.3389\/fendo.2023.1256093","article-title":"The role of C-peptide in diabetes and its complications: An updated review","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.cca.2026.120829_bb0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.18097\/pbmc20206603196","article-title":"Molecular mechanisms of action and physiological effects of the proinsulin C-peptide (a systematic review)","volume":"66","author":"Poteryaeva","year":"2020","journal-title":"Biomed. Khim."},{"issue":"2","key":"10.1016\/j.cca.2026.120829_bb0125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/ijms21020645","article-title":"Multiple cell signalling pathways of human proinsulin C-peptide in vasculopathy protection","volume":"21","author":"Souto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cca.2026.120829_bb0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diabres.2015.01.016","article-title":"C-peptide: New findings and therapeutic possibilities","volume":"107","author":"Wahren","year":"2015","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cca.2026.120829_bb0135","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.21474\/IJAR01\/8770","article-title":"Serum c-peptide concentrations in women with polycystic ovarian syndrome (PCOS)","volume":"7","author":"Dharshini","year":"2019","journal-title":"Int. J. Adv. Res."},{"issue":"4","key":"10.1016\/j.cca.2026.120829_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.25130\/tjps.v23i4.515","article-title":"Estimation the activity of Copeptin, insulin, and C-peptide from patients with polycystic ovary syndrome","volume":"23","author":"Sarhat","year":"2018","journal-title":"Tikrit J. Pure Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.120829_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4093\/dmj.2011.35.1.41","article-title":"Basal C-peptide level as a surrogate marker of subclinical atherosclerosis in type 2 diabetic patients","volume":"35","author":"Kim","year":"2011","journal-title":"Diabetes Metab. J."},{"issue":"6","key":"10.1016\/j.cca.2026.120829_bb0150","doi-asserted-by":"crossref","first-page":"E986","DOI":"10.1210\/jc.2011-0031","article-title":"The lipid accumulation product is associated with impaired glucose tolerance in PCOS women","volume":"96","author":"Wehr","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cca.2026.120829_bb0155","first-page":"646","article-title":"Serum magnesium and C-peptide levels in Iraqi women with polycystic ovary syndrome","volume":"41","author":"Al-rubayee","year":"2024","journal-title":"J. Exp. Clin. Med."},{"issue":"6","key":"10.1016\/j.cca.2026.120829_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.003152","article-title":"Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults","volume":"1","author":"Patel","year":"2012","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.cca.2026.120829_bb0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cen.12619","article-title":"Biomarkers and insulin sensitivity in women with polycystic ovary syndrome: Characteristics and predictive capacity","volume":"83","author":"Cassar","year":"2015","journal-title":"Clin. Endocrinol."},{"issue":"8","key":"10.1016\/j.cca.2026.120829_bb0170","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1515\/cclm-2017-0029","article-title":"Preparation, calibration and evaluation of the first international standard for human C-peptide","volume":"55","author":"Moore","year":"2017","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"03","key":"10.1016\/j.cca.2026.120829_bb0175","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/a-1998-6889","article-title":"Comparability of C-peptide measurements\u2013current status and clinical relevance","volume":"131","author":"H\u00f6rber","year":"2023","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"1","key":"10.1016\/j.cca.2026.120829_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5114\/pedm.2022.113741","article-title":"Which C-peptide assay do you use? increasing need for describing C-peptide assay performance","volume":"28","author":"Dekker","year":"2025","journal-title":"Pediatr. Endocrinol. Diabetes Metab."},{"key":"10.1016\/j.cca.2026.120829_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmsacl.2025.02.001","article-title":"MRM-based LC-MS method for accurate C-peptide quantitation","volume":"36","author":"Grothoff","year":"2025","journal-title":"J. Mass Spectrometry Adv. Clin. Lab"},{"issue":"7","key":"10.1016\/j.cca.2026.120829_bb0190","article-title":"Secondary Hirata syndrome in a neonate: Practical approach and management","volume":"2","author":"Perri","year":"2024","journal-title":"JCEM Case Rep."},{"issue":"6","key":"10.1016\/j.cca.2026.120829_bb0195","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/clinchem\/hvab043","article-title":"Increased C-peptide immunoreactivity in insulin autoimmune syndrome (Hirata disease) due to high molecular weight proinsulin","volume":"67","author":"Kay","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.120829_bb0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jmsacl.2022.06.003","article-title":"Multiplexed quantification of insulin and C-peptide by LC-MS\/MS without the use of antibodies","volume":"25","author":"Foulon","year":"2022","journal-title":"J. Mass Spectrometry Adv. Clin. Lab"},{"issue":"1","key":"10.1016\/j.cca.2026.120829_bb0205","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1038\/s41598-023-37513-2","article-title":"Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population","volume":"13","author":"Mansour","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cca.2026.120829_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030732","article-title":"Body composition, serum concentrations of androgens and insulin resistance in different polycystic ovary syndrome phenotypes","volume":"9","author":"Polak","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.cca.2026.120829_bb0215","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2337\/dc23-1070","article-title":"Longitudinal effects of glucose-lowering medications on \u03b2-cell responses and insulin sensitivity in type 2 diabetes: The GRADE randomized clinical trial","volume":"47","author":"Rasouli","year":"2024","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.cca.2026.120829_bb0220","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4183\/aeb.2023.31","article-title":"C-peptide as an inflammatory marker in obese women","volume":"19","author":"Can","year":"2023","journal-title":"Acta Endocrinol. (Bucharest)"},{"issue":"2","key":"10.1016\/j.cca.2026.120829_bb0225","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4103\/JCMRP.JCMRP_111_18","article-title":"Evaluation of C-peptide and insulin resistance in nondiabetic patients with chronic kidney disease","volume":"6","author":"Mustafa","year":"2021","journal-title":"J. Curr. Med. Res. Practice"},{"issue":"2","key":"10.1016\/j.cca.2026.120829_bb0230","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2022-003201","article-title":"High levels of serum C-peptide are associated with a decreased risk for incident renal progression in patients with type 2 diabetes: A retrospective cohort study","volume":"11","author":"Yang","year":"2023","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.cca.2026.120829_bb0235","series-title":"C-Peptide Involvement in the Progression of Type 2 Diabetes Mellitus through Triglyceride-Centered Lipid Metabolism Disorders","author":"Li","year":"2024"},{"issue":"3","key":"10.1016\/j.cca.2026.120829_bb0240","doi-asserted-by":"crossref","DOI":"10.22317\/jcms.v8i3.1220","article-title":"Roles of C-peptide and triglyceride as effective indices for insulin resistance investigations in Iraqi women with polycystic ovarian syndrome","volume":"8","author":"Al-Murshedi","year":"2022","journal-title":"J. Contemporary Med. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.120829_bb0245","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2025.2458710","article-title":"Improved insulin sensitivity and reproductive profile in overweight\/obese PCOS patients undergoing integrative treatment with carnitines, L-arginine, L-cysteine and myo-inositol","volume":"41","author":"Genazzani","year":"2025","journal-title":"Gynecol. Endocrinol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:59:53Z","timestamp":1772355593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126000112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S0009898126000112"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.120829","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-peptide in polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.120829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120829"}}